Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 562.00
Bid: 560.00
Ask: 568.00
Change: 12.00 (2.18%)
Spread: 8.00 (1.429%)
Open: 560.00
High: 562.00
Low: 550.00
Prev. Close: 550.00
GHH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Divestment of EM4

18 Mar 2024 14:36

RNS Number : 2868H
Gooch & Housego PLC
18 March 2024
 

 

18 March 2024

 

Gooch & Housego PLC

("G&H" or the "Company" or the "Group")

 

Divestment of EM4

 

Completion of an important milestone on the rationalisation of the Group's A&D product portfolio

 

 

Gooch & Housego PLC (AIM: GHH), the specialist manufacturer of photonic components and systems announces that it has sold its subsidiary EM4, LLC to EMFOUR Acquisition Co., LLC, a subsidiary of a US-based global technology company (the "Buyer") for a total consideration of up to $12.0m (£9.4m) (the "Disposal").

 

The EM4 business, located near Boston (MA), manufactures optoelectronic components and laser modules primarily for the US A&D market. The business also manufactured and supplied fused fibre couplers, but this product line has been excluded from the sale and transferred to the Group's Torquay facility.

 

The total consideration payable of up to $12.0m comprises an initial consideration of $5.25m (£4.1m) and deferred consideration of up to $6.75m (£5.3m). The initial consideration will be settled in cash subject to customary adjustments for working capital, cash and debt at completion. The deferred consideration, which is based upon the performance of the EM4 business in the period ending 30 September 2025, will be settled in cash. The net proceeds of the Disposal will be used to reduce the Group's borrowings.

 

In the Group's results for the year ended 30 September 2023, the elements of the EM4 business that are subject to the sale contributed £13.4m of revenue and delivered a loss before tax of £0.7m. Some of the Group's global function resources previously charged to the EM4 business will be redeployed following the Disposal to support the execution of the Group's strategy. At 31 January 2024, the book value of the gross assets of the business totalled £12.4m. The Disposal and its associated costs are expected to generate a non-underlying charge of circa £8.0m (cash effect circa £1.5m). The transaction is expected to be marginally accretive to underlying earnings for the year ending 30 September 2024.

Charlie Peppiatt, Chief Executive Officer of Gooch and Housego, commented:

"I am pleased to be able to report the completion of an important milestone on our journey to deliver sustainable margin growth for the Group. The divestment of EM4 is the result of a carefully considered and ongoing review of our A&D product portfolio."

"The Disposal supports the Group's consolidation of our A&D activities into areas where we can offer differentiated products to our customers and enable the Group to grow our optical systems business and maximise value creation from accretive optical systems solutions."

"I would like to thank the EM4 team in Boston for their contribution to G&H and wish them well for the future."

 

 

For further information please contact:

 

Charlie Peppiatt, Chief Executive Officer

Chris Jewell, Chief Financial Officer 

Gooch & Housego PLC

+44 (0) 1460 256440

 

Mark Court / Sophie Wills / Abigail Gilchrist

G&H@buchanan.uk.com

Buchanan

+44 (0) 20 7466 5000

 

Christopher Baird / David Anderson

Investec Bank plc

+44 (0) 20 7597 5970

 

 

Notes to editors

 

1. Gooch & Housego is a photonics technology business headquartered in Ilminster, Somerset, UK with operations in the USA and Europe. A world leader in its field, the company researches, designs, engineers and manufactures advanced photonic systems, components and instrumentation for applications in the Aerospace & Defence, Industrial, Life Sciences and Scientific Research sectors. World leading design, development and manufacturing expertise is offered across a broad range of complementary technologies.

 

2. All financial information included in this announcement is sourced from unaudited management accounts and excludes any specific items. This announcement contains certain forward-looking statements that are based on management's current expectations or beliefs as well as assumptions about future events. These are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the countries and sectors in which G&H operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results, and G&H's plans and objectives, to differ materially from those currently anticipated or implied in the forward-looking statements. Investors should not place undue reliance on any such statements. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBSGDXSXBDGSI
Date   Source Headline
24th Jun 20087:00 amRNSChange of NOMAD & Broker
17th Jun 20087:00 amRNSInterim Results
27th May 20087:00 amRNSIFRS
13th May 20086:00 amRNSNotice of Results
9th Apr 20087:00 amRNSTrading Update
28th Mar 20089:59 amRNSAnnual Report and Accounts
12th Mar 20084:37 pmRNSAdditional Listing
13th Feb 200811:00 amRNSAGM Statement
5th Feb 20087:01 amRNSVendor Appreciation Award
22nd Jan 20087:01 amRNSGlobal Integration
7th Jan 20088:53 amRNSAdditional Listing
7th Jan 20087:01 amRNSSIFAM Order
4th Jan 200812:32 pmRNSDirector Shareholding
21st Dec 20074:46 pmRNSHolding(s) in Company
21st Dec 20074:35 pmRNSAdditional Listing
7th Dec 20073:00 pmRNSLong Term Incentive Plan
3rd Dec 200712:20 pmRNSAdditional Listing
30th Nov 20073:44 pmRNSHolding(s) in Company
27th Nov 20077:00 amRNSAppointment
27th Nov 20077:00 amRNSPreliminary Results
15th Nov 20077:01 amRNSAppointment
29th Oct 20077:01 amRNSNotice of Results
4th Oct 20077:01 amRNSFull Year Trading Update
23rd Aug 20078:26 amRNSAdditional Listing
22nd Aug 20075:38 pmRNSDirector Shareholdings
17th Aug 20076:23 pmRNSAIM Rule 26
16th Aug 20072:12 pmRNSAdditional Listing
14th Aug 200712:36 pmRNSLTIP Awards
10th Aug 20075:18 pmRNSDirector Shareholdings
17th Jul 20074:16 pmRNSDirector of Sales Appointment
5th Jun 20077:02 amRNSInterim Results
31st May 20079:55 amRNSTotal Voting Rights
10th May 20079:58 amRNSHolding(s) in Company
9th May 20077:01 amRNSNotice of Results
8th May 20071:53 pmRNSAdditional Listing
8th May 20077:02 amRNSAcquisition
11th Apr 20077:01 amRNSTrading Update
8th Mar 20075:54 pmRNSHolding(s) in Company
14th Feb 20077:01 amRNSAGM Statement
8th Feb 20073:41 pmRNSHolding(s) in Company
1st Feb 200712:43 pmRNSTotal Voting Rights
1st Feb 200712:42 pmRNSHolding(s) in Company
9th Jan 200710:26 amRNSAdditional Listing
20th Dec 200611:54 amRNSTotal Voting Rights
30th Nov 200610:07 amRNSNotice of Dividend
29th Nov 200611:18 amRNSPreliminary Results-Amendment
29th Nov 20067:02 amRNSAppointment of Director
29th Nov 20067:02 amRNSPreliminary Results
2nd Nov 20067:01 amRNSNotice of Results
4th Oct 20067:00 amRNSFull Year Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.